These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1241781)

  • 21. Established cell line sensitive to influenza C virus.
    Nerome K; Nakayama M; Ishida M
    J Gen Virol; 1979 Apr; 43(1):257-9. PubMed ID: 113496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of species and organ-specific features of tissue systems on the reactogenic and immunogenic properties of influenza virus.
    Gorev NE
    Acta Virol; 1975 Jan; 19(1):41-6. PubMed ID: 235196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the growth of influenza virus type C in hen's embryo (other than amniotic and allantoic) and in tissue culture.
    Prasad AK
    Indian J Chest Dis Allied Sci; 1976 Apr; 18(2):63-72. PubMed ID: 829119
    [No Abstract]   [Full Text] [Related]  

  • 24. Overcoming nutrient limitations for cell-based production of influenza vaccine.
    Liu XP; Huang D; Tan WS; Luo J; Chen Z
    Hum Vaccin Immunother; 2015; 11(7):1685-8. PubMed ID: 26061797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplication and plaque assay of influenza viruses in a continuous cell line (G2) of human origin.
    Hatano M; Morita O
    Arch Gesamte Virusforsch; 1967; 20(3):305-13. PubMed ID: 5598018
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic interaction between two influenza A-WS virus mutants. I. Characterization of the mutants.
    Tucková E; Vonka V; Stárek M
    Acta Virol; 1971 Sep; 15(5):337-44. PubMed ID: 4399131
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic infection of the RES line of transplantable embryonic pig cells caused by a variant of influenza AO-WSN virus. 1. A variant of influenza WSN-RES-16 virus and culture RES-WSN "recovering" from chronic infection].
    Gavrilov VI; Vialushkina SIa; Asher DA; Ratushkina LS; Tumian BG; Zmieva RG
    Vopr Virusol; 1970; 15(5):605-10. PubMed ID: 4994383
    [No Abstract]   [Full Text] [Related]  

  • 28. Propagation of type A Myxovirus influenzae in diploid cell strain WI-38. I. Adaptation experiments with strains of human and animal origin.
    Tůmová B; Fedová D
    Acta Virol; 1968 Jul; 12(4):324-30. PubMed ID: 4386017
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhanced production of human influenza virus in PBS-12SF cells with a reduced interferon response.
    Carvajal-Yepes M; Sporer KR; Carter JL; Colvin CJ; Coussens PM
    Hum Vaccin Immunother; 2015; 11(9):2296-304. PubMed ID: 26090991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of cell separation in culture under the effect of influenza viruses].
    Sidorenko OV; Grashchenko TB; Kolotukha NIa
    Mikrobiol Zh; 1972; 34(1):42-5. PubMed ID: 5077254
    [No Abstract]   [Full Text] [Related]  

  • 31. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
    Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
    Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Production of influenza virus recombinations].
    Herrmann B
    Arch Exp Veterinarmed; 1978; 32(3):455-64. PubMed ID: 697531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.
    Minor PD; Engelhardt OG; Wood JM; Robertson JS; Blayer S; Colegate T; Fabry L; Heldens JG; Kino Y; Kistner O; Kompier R; Makizumi K; Medema J; Mimori S; Ryan D; Schwartz R; Smith JS; Sugawara K; Trusheim H; Tsai TF; Krause R
    Vaccine; 2009 May; 27(22):2907-13. PubMed ID: 19366582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obtention of M. parainfluenzae 4 (A and B) hemagglutinin utilizable for the hemagglutination inhibition reaction].
    Henry M; Jean MT; Sohier R
    Ann Inst Pasteur (Paris); 1968 Dec; 115(6):1107-13. PubMed ID: 4306173
    [No Abstract]   [Full Text] [Related]  

  • 35. Ts mutant of NWS influenza virus: behaviour in vitro and in vivo.
    Tucková E; Svobodová J; Anisimová E; Doleźalová B; Vonka V; Stárek M
    Acta Virol; 1976 Aug; 20(4):305-12. PubMed ID: 9820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A2-Hong Kong influenza virus infection and lipid changes in primary human and other cell types.
    De Sousa CP; Filipe MI
    Acta Virol; 1972 Jun; 16(1):17-24. PubMed ID: 4110512
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of cell culture respiration by influenza virus strains of different virulence.
    Voitsekhovsky BL; Polyak RY
    Acta Virol; 1972 Jul; 16(4):313-22. PubMed ID: 4403173
    [No Abstract]   [Full Text] [Related]  

  • 38. Interference between A2 and B influenza viruses and adenovirus in cell culture.
    Shenderovick SF; Zakstelskaya LY; Korabelnikova NI
    Acta Virol; 1973 May; 17(3):203-8. PubMed ID: 4147138
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of an established canine kidney-cell line.
    Brown AL; Davis EV; Beckenhauer WH
    Cornell Vet; 1968 Oct; 48(4):593-613. PubMed ID: 4301040
    [No Abstract]   [Full Text] [Related]  

  • 40. Influenza viruses in cell cultures. 3. Propagation in calf kidney cells.
    Lehmann-Grube F; Fazekas de St Groth
    Arch Gesamte Virusforsch; 1965; 17(5):534-48. PubMed ID: 5894327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.